about
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Th...
Read More
3.91
0.16
(4.27%)
680.8K
XNAS Volume
XNAS 09 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Agenus Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..